A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist-Reference-Cited by-同舟云学术

A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist

Published:2017-01-09 Issue:13 Volume:23 Page:3416-3427
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Leyland Rebecca,Watkins Amanda,Mulgrew Kathy A.,Holoweckyj Nicholas,Bamber Lisa,Tigue Natalie J.,Offer Emily,Andrews John,Yan Li,Mullins Stefanie,Oberst Michael D.,Coates Ulrichsen Jane,Leinster David A.,McGlinchey Kelly,Young Lesley,Morrow Michelle,Hammond Scott A.,Mallinder Philip,Herath Athula,Leow Ching Ching,Wilkinson Robert W.,Stewart Ross

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Flow Cytometry in Drug Discovery and Translational Research;International Journal of Molecular Sciences;2024-03-29

2. Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targeting;American Journal of Cancer Research;2024

3. The benefits of clustering in TNF receptor superfamily signaling;Frontiers in Immunology;2023-08-17

4. Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes;Cells;2023-06-09

5. The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy;Cancers;2023-03-07